Efficacy of Venetoclax Combined With Intensive Chemotherapy in Different Subgroups of AML
Clinical trial NCT06635681 · RECRUITING
Trial details
- NCT number
- NCT06635681
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-29
- Primary completion
- 2026-12-01
- Enrollment
- 380
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.